To keep up with advances in artificial intelligence and machine learning in the health-care sector, US FDA is working to develop a draft guidance that would help sponsors gain clarity on what the agency expects from them.
FDA Commissioner Scott Gottlieb issued a statement on April 2 espousing the potential of AI to change the face of health care. He timed it with the release of a